Paris - Tour de France director Christian Prudhomme wants cycling authorities
to act quickly in their investigation of four-time champion Chris
Froome has been ordered to explain to the International
Cycling Union why a urine sample he provided at the Spanish Vuelta in
September showed a concentration of the asthma drug salbutamol that was
twice the permitted level.
"We want the situation to be cleared
up, to get out of the darkness and ambiguity," Prudhomme told France
Info TV on Friday.
"We obviously want an investigation to be conducted,
and we don't want it to last for months and months, so we can have an
answer from the UCI as soon as possible next season."
If found guilty of doping, the 32-year-old Froome could lose his Vuelta title and be suspended.
has planned to ride in the Tour next year and Prudhomme wants to avoid a
repeat of the scenario that saw Alberto Contador race and win the Giro
in 2011 despite a positive test for clenbuterol. His title was later
stripped and given to Michele Scarponi after the Court of Arbitration
for Sport gave the Spaniard a two-year ban.
Froome won his fourth Tour title this year and followed it with a victory at the Vuelta.
helps expand lung capacity and can be used as a performance-enhancing
drug to increase endurance. Salbutamol is classified as a beta-2 agonist
and the World Anti-Doping Agency allows it to be taken through
inhalation only, in limited amounts.
Sky said Froome had to take
an increased dosage of the drug without exceeding the permissible dose
after he "experienced acute asthma symptoms" during the final week of
"Salbutamol is not a banned substance," Prudhomme
"What matters is the amount taken, that's why an expert battle
will take place, although it looks like the dose found was twice the